https://almorexantantagonist.c....om/display-and-upsho
The secondary outcome measures encompassed successful reperfusion (modified Thrombolysis in Cerebral Infarction score 2b), the modified Rankin Scale score on discharge, the ordinal modified Rankin Scale score, and 90-day mortality. From a cohort of 685 patients, a subset of 623 (mean age [standard deviation]: 67 [122] years; 406 [652%] male) were selected for analysis. Of this subset, 363 (584%) were allocated to the CAS group and 260 (416%) to the non-stenting group. The CAS group had few
Like
Comment
Share
